Abdel-Rahman O - Search Results

1

Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

Mete O, Boucher A, Schrader KA, Abdel-Rahman O, Bahig H, Ho C, Hasan OK, Lemieux B, Winquist E, Wong R, Wu J, Chau N, Ezzat S. Mete O, et al. Among authors: abdel rahman o. Endocr Pathol. 2024 Dec;35(4):293-308. doi: 10.1007/s12022-024-09836-x. Epub 2024 Nov 23. Endocr Pathol. 2024. PMID: 39579327 Free PMC article.

2

The role of surgery in small differentiated thyroid cancer.

Baidoun F, Abdel-Rahman O. Baidoun F, et al. Endocrine. 2022 Sep;77(3):469-479. doi: 10.1007/s12020-022-03097-6. Epub 2022 Jun 3. Endocrine. 2022. PMID: 35657579

3

Changes in the outcomes of patients with anaplastic thyroid carcinoma over the past two decades.

Abdel-Rahman O, Ghosh S. Abdel-Rahman O, et al. Endocrine. 2024 Apr;84(1):155-159. doi: 10.1007/s12020-023-03556-8. Epub 2023 Oct 7. Endocrine. 2024. PMID: 37804443

4

Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

Mete O, Boucher A, Schrader KA, Abdel-Rahman O, Bahig H, Ho C, Hasan OK, Lemieux B, Winquist E, Wong R, Wu J, Chau N, Ezzat S. Mete O, et al. Among authors: abdel rahman o. Endocr Pathol. 2024 Dec;35(4):309-310. doi: 10.1007/s12022-024-09843-y. Endocr Pathol. 2024. PMID: 39641850 Free PMC article. No abstract available.

5

Assessment of the AJCC staging system of pheochromocytomas/paragangliomas.

Abdel-Rahman O. Abdel-Rahman O. Endocrine. 2022 Jan;75(1):239-243. doi: 10.1007/s12020-021-02854-3. Epub 2021 Aug 27. Endocrine. 2022. PMID: 34449032

6

New paradigms in the treatment of low-risk thyroid cancer.

Baidoun F, Saad AM, Abdel-Rahman O. Baidoun F, et al. Expert Rev Endocrinol Metab. 2020 Jul;15(4):251-260. doi: 10.1080/17446651.2020.1773802. Epub 2020 Jun 8. Expert Rev Endocrinol Metab. 2020. PMID: 32511023 Review.

7

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.

Anaka M, Abdel-Rahman O. Anaka M, et al. Cancer Manag Res. 2022 Jan 23;14:273-285. doi: 10.2147/CMAR.S273544. eCollection 2022. Cancer Manag Res. 2022. PMID: 35115827 Free PMC article. Review.

8

Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management.

Fawaz A, Abdel-Rahman O. Fawaz A, et al. Cancer Manag Res. 2022 Dec 28;14:3589-3598. doi: 10.2147/CMAR.S340719. eCollection 2022. Cancer Manag Res. 2022. PMID: 36597515 Free PMC article. Review.

9

Remission of Ectopic Cushing Syndrome Secondary to Medullary Thyroid Cancer With Vandetanib and Selpercatinib.

Jazdarehee A, Abdel-Rahman O, Jacquier JE. Jazdarehee A, et al. Among authors: abdel rahman o. JCEM Case Rep. 2024 Jan 27;2(2):luad174. doi: 10.1210/jcemcr/luad174. eCollection 2024 Feb. JCEM Case Rep. 2024. PMID: 38283729 Free PMC article.

10

Population-based assessment of the performance of sigmoidoscopy in the detection of colorectal cancer: implications for future screening recommendations.

Abdel-Rahman O, Cheung WY. Abdel-Rahman O, et al. J Gastrointest Oncol. 2019 Apr;10(2):354-356. doi: 10.21037/jgo.2018.10.12. J Gastrointest Oncol. 2019. PMID: 31032105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters